• Latest Posts

Stargardt disease treatment gets FDA fast track

Visiox Pharma announces FDA acceptance of glaucoma new drug application

FDA clears SparingVision’s investigational new drug application to treat ocular diseases

Interview 28 Nov 2022

Breaking barriers to gene therapies for childhood rare diseases

More News! 10 Nov 2022

Eye disease therapies being developed after Breye Therapeutics’ €4M seed financing

Replay Bio launches HSV gene therapy company to target retinal eye disease


Syncona to acquire Applied Genetic Technologies Corporation

Protocol for treatment of neurotrophic keratopathy submitted to FDA by ReGenTree

SparingVision raises €75M for genomic medicines for ocular diseases

The five hottest private biotech companies in India

Improved vision with less eye injections for patients after primary endpoints met in trials

Marketing authorization granted for treatment of serious retinal diseases